Financials

  • Market Capitalization 2.98 B
  • Employee 339
  • Founded 2016
  • CEO N/A
  • Website www.veratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00Q72WYG3
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-7.26
ratio cours/chiffre d'affaires
-2 982.67

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1679
ELVN
Enliven Therapeutics, Inc. - Common Stock
50.87 USD-0.43%+1.27%+11.48%+146.22%3.10 B USD
1701
CLDX
Celldex Therapeutics, Inc. - Common Stock
38.53 USD-1.48%+1.39%+21.47%+41.45%3.02 B USD
1736
IRON
Disc Medicine, Inc. - Common Stock
75.98 USD-0.80%-2.71%+10.02%+31.02%2.90 B USD
1822
QURE
uniQure N.V. - Ordinary Shares
41.10 USD-3.59%-1.93%+48.11%+181.51%2.59 B USD

Nouvelles